Introduction
Celiac disease (CD) is a common autoimmune disorder, which develops in genetically predisposed/susceptible individuals (HLA-DQ2/DQ8 positive) as a result of intolerance to dietary gluten. The disease is characterised by mucosal villous atrophy with crypt hyperplasia, and immune cell infiltration in the small intestinal mucosa causing severe inflammation. Treatment of CD consists of a lifelong gluten-free diet (GFD), which causes clinical improvement and normalisation of the mucosal villous atrophy, including improvement of the intestinal inflammation. T-cells reacting against transglutaminase deamidated gliadin have been reported to be interferon (IFN)-γ secreting cells emphasising the role of T-helper (Th) 1 response in the pathogenesis [1] . The exact mechanism by which gluten damages the intestinal mucosa is unknown. IFN-γ alters the epithelial barrier function [2] and both IFN-γ and tumor necrosis factor (TNF)-α have been shown to increase intestinal permeability by disruption of tight junctions [3] .
The small intestinal inflammation in untreated CD is characterised by increased numbers of intraepithelial lymphocytes (IEL), lamina propria lymphocytes (LPL) and dendritic cells [4] [5] [6] . The intestinal immune cells in CD produce IFN-γ and TNF-α [4, 7, 8] , which are believed to be involved in the pathogenesis. The janus kinase -signal transducer and activator of transcription (JAK-STAT) pathway, which mediates a Th1 (IFN-γ) response through activation of STAT proteins, has been reported to be of importance in the CD pathogenesis [7, 9] . Apart from IFN-γ, also other cytokines as IFN-α/β, interleukin (IL) 6, TNF-α and transforming growth factor (TGF)- that can activate or cross-talk with the JAK-STAT signalling pathway are suggested to be of importance in CD [10, 11] .
A dysregulated intestinal immune system is regarded as a plausible cause of the aberrant immune response against the transglutaminase modified gliadin peptide(s). In healthy mucosa transglutaminase modified gliadin peptides are tolerated and do not trigger intestinal inflammation in the majority of individuals who carry the CD related risk genotype. Thus, the intestinal dysregulation that results in full-blown CD likely also depends on other factors than gluten exposure, which makes it reasonable not to expect full normalisation whendietary gluten is removed. Follow-up biopsies taken after GFD treatment is no longer used as routine in diagnosing CD, hence it is very difficult to study a possible underlying immune dysregulation related to CD, i.e. not caused by the dietary gliadin. In Sweden we followed the effects of GFD with follow-up biopsies until recently, and thereby have a unique opportunity to compare the intestinal immune reaction in patients untreated and after treatment with GFD.
In this study we have analysed the expression pattern of Th1-Th2-Th3 associated genes in the small intestine and in the peripheral blood from children with CD before and after one -year of treatment with GFD.
Method

Study population
Small intestinal biopsy specimens and venous blood were obtained from 7 children with CD (mean age: 8 years, range: 2-13 years, 4 girls & 3 boys), both before and after 1 year of strictly GFD (Table 1 ). All of the studied children were under investigation for suspected CD at the Paediatric Clinic, University Hospital Linköping or at the Paediatric Clinics in Norrköping or Motala. They had undergone an initial small intestinal biopsy, which showed a typical morphological picture suggesting CD and the second biopsy after one -year of strict GFD demonstrated improvement /normalisation of the mucosa.
For reference, we studied small intestinal biopsy specimens and venous blood from 6 reference children (mean age: 6 years (range: 1-11 years), 4 girls & 2 boys) who performed a small intestinal biopsy due to a suspicion of CD, but who displayed a morphologically normal mucosa ( Table 1) .
The reference children were all on a normal diet containing gluten.
Preparation of PBMC & biopsies
Venous blood samples were drawn into heparin treated tubes (Vacuette, Greiner Labortechnik, Kremsmünster, Austria). Peripheral blood mononuclear cells (PBMC) were separated on Ficoll Paque Density gradient (Amersham, Pharmacia, Biotech, Uppsala, Sweden) according to standardised methodology and cryopreserved in freezing medium (50% fetal calf serum, 40% RPMI 1640 and 10% DMSO) (Sigma-Aldrich, Stockholm, Sweden). After thawing of the PBMC, the cell viability was checked with Trypan blue (Sigma-Aldrich) exclusion test. The cells were washed in cold (4C) PBS and lysed using RLT lysis buffer (Qiagen, Hilden, Germany) with β-ME (Sigma, Stockholm, Sweden). Small intestinal biopsy specimens were divided for routine histology and the surplus was used for PCR-array studies. At surgery, the biopsies were immediately placed in RPMImedium, transported to the laboratory, snap-frozen and cryopreserved in N2.
RNA preparation
Total RNA was isolated from the PBMC-lysates using QIA shredders (Qiagen, Hilden, Germany) and RNeasy® Mini Kit (Qiagen), including on column DNase treatment with RNase-Free DNase Set (Qiagen), according to the manufacturer´s guidelines. Similarly, total RNA was isolated from cryopreserved biopsy specimens by homogenisation using Stainless Steel Beads, Tissue Lyser II (Qiagen) and RNeasy® Mini Kit (Qiagen) including on column DNase treatment with RNase-Free DNase Set (Qiagen), according to the manufacturer´s guidelines. The RNA quality and quantity was checked with RNA 6000 Nano LabChip® Kit (Agilent Technologies, Palo Alto, CA, USA) on an Agilent 2100 Bioanalyzer (Agilent Technologies), according to the manufacturer´s guidelines.
RT-PCR and Real-time-PCR-arrays
Reverse transcription of 1 μg total RNA into first strand cDNA was performed with the RT2 PCRarray First strand Kit (SuperArray, Gaithersburg, MD, USA), according to the manufacturer´s guidelines. In brief, DNase treatment (42°C for 5 min) and reverse transcription was performed (42°C for 15 min followed by 95°C for 5 min).
A PCR cocktail, containing: RT2 Real-Time SYBR®Green/ROX qPCR Master Mix (containing HotStart DNA polymerase, SYBR®Green dye, and ROX reference dye) (SuperArray), doubledistilled H2O and cDNA, was loaded in each of the 96 wells of the Human Th1-Th2-Th3 RT² Profiler™ PCR Array (PAHS-034, SuperArray). PCR amplification was performed, by ABI 7500
Fast Real-Time-PCR System (Applied Biosystems, Foster City, CA, USA), with an initial 10-min step at 95°C followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Baseline and threshold values were set manually, using the 7500 System Software (Applied Biosystems), and were the same across all PCR-array runs in the same analysis, according to the producer´s recommendations.
Only genes with threshold cycle (Ct)-values <35 were considered to be detectable (due to the low copy numbers of the genes in samples with Ct-values >35), according to the manufacturer´s guidelines. The Ct-values were normalised with the average Ct-value of all (five) housekeeping genes (HKG) on the array: Beta-2-microglobulin (B2M), Hypoxanthine phosphoribosyltransferase 1 (HPRT1), Ribosomal protein L13a (RPL13A), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin (ACTB). The ΔCt and the median fold change (2 -MEDIAN ΔΔCt ) were calculated for the genes on the array.
Statistics
Statistical analysis was performed using the SPSS for Windows version 14.0 (SPSS, Chicago, USA In order to disclose multivariate responses Principal Component Analysis (PCA) of the HKGnormalised Real-time-PCR-array data was employed, using GeneEx (MultiD Analyses/TATAA Biocenter, Gothenburg, Sweden). The data was pre-processed by calculating the relative expression of the genes, log2-transformation and mean-centering. Genes passing the double cut-off criteria; the fold change cut-off together with a significant difference in gene expression between the study groups (Mann-Whitney or Wilcoxon p<0.05; between Untreated-CD and/or GFD-treated-CD and/or Reference), were visualised with PCA.
Ethics
The study was approved by the Regional Ethics Committee for Human Research at the University Hospital of Linköping and written informed consent was obtained from the families.
Results
Detectable PCR products (<35 cycles) were obtained from the majority of the 84 Th1-Th2-Th3 genes on the array (Supplementary table 1 ). The expression level of 14 genes in biopsies and 9 genes in PBMC were lower than the established detection level (<35 cycles) in the majority of the study subjects and were therefore excluded from the statistical analyses (Supplementary table 1) . 
Expression of
Normalised by GFD
As response to GFD, the expression of Th2 related genes, such as IL-4R, IL-13RA1, IL-5, STAT6
as well as JAK1 and MAF, increased in the patients, and no differences were seen between treated CD children and the reference group (Supplementary table 2a, Figure 3b ). The decreased expression of IL-18, CREB binding protein (CREBBP) and TGF-β3 at diagnosis was normalised with GFD (Supplementary table 2a , Figure 3b ).
Expression of Th1-Th2-Th3 genes in PBMC, the peripheral circulation
In contrast to the observations noted in the biopsies, the expression of the altered mucosal Th1 or Th2 markers did not differ between PBMCs from CD and reference children. Instead, increased expression of other Th1 related genes, such as T-box 21 (TBX21) transcription factor and STAT4
were noted in the peripheral blood mononuclear cell population from children with CD, both at diagnosis and after GFD, when compared to the reference children (Supplementary table 2b ).
Children with CD had down regulated ICOS and suppressor of cytokine signalling (SOCS) 1 expression both at diagnosis and after GFD-treatment (Supplementary table 2b) .
A high expression of chemokine ligand 5 (CCL5), IL-15, IL-18, IL-18R was seen in PBMC in
untreated CD children compared to the reference children, and this high expression was not affected by the GFD (Supplementary table 2b, Figure 3a) . Additionally, children with untreated CD had increased levels of fas ligand (FASL), G protein-coupled receptor 44 (GPR44) and MAF compared to the reference group. The GPR44 expression remained elevated after the GFD-treatment (Supplementary table 2b ).
The expression of TNFSFR9 and MAPK8 were elevated in PBMCs (from untreated) from CD children both before and after GFD-treatment in comparison to non-CD children (Supplementary   table 2b ).
Multivariate analysis of intestinal and peripheral immune responses with PCA
PCA visualisation of the genes with significant differences (fold change and p≤ 0.05) in intestinal and peripheral expression (20 and 17 genes, respectively), revealed separation between the three study groups: untreated-CD, GFD-treated-CD and references ( Figure 4 and Figure 5 , respectively).
Discussion
We followed the immune activation stage in the intestinal biopsies from CD-children taken at presentation and after a year of GFD treatment and evaluated whether the intestinal immune dysregulation remains after gluten removal. This dysregulation observed after GFD which results in mucosal healing should reasonably depend on other factors than gluten, which may be important in the development of intolerance to gluten and CD.
Real-time-PCR-arrays were used to study the Th1-Th2-Th3 gene expression profiles in small intestinal biopsies and PBMC from children with CD. The method combines Real-time-PCR and microarray technology, yielding a sensitive method to study many genes simultaneously. The PCRarray system yields high positive call rates and has a high reproducibility [12] , which was confirmed in our study where the majority of the 84 genes were detectable. In our study, the five house keeping genes included on the array were used for normalisation of the 84 Th1-Th2-Th3 genes [12, 13] and fold-change cut-off values were used for altered expression levels as has previously been described [12, [14] [15] [16] [17] .
As expected we found that the Th1 expression profile including IFN-γ, STAT1 and IRF1 was pronounced in the small intestinal biopsies from untreated children with CD. Although GFD for one year did down regulate these markers the expression of STAT1 and IRF1 genes were still elevated in treated children with CD compared to reference children. The findings in our study are in agreement with previous reports of the increased intestinal IFN-γ and STAT1 expression in untreated CD both at RNA and protein level [7, 9, [18] [19] [20] [21] [22] . Further, IRF1 which is involved in IFN-γ [23, 24] and TNF mediated responses [25] via regulation of the induction of NO/iNOS in macrophages [24, 26] has previously been reported to be elevated at RNA and protein level in biopsies from untreated CD children [18] . The novelty of our study is the fact that we show persistent activation of the Th1 (IFN-γ) signalling pathway markers STAT1 and IRF1 in the small intestine of CD children despite GFD treatment. This suggests that STAT1 and IRF1 are associated with a basic dysregulation of the immune system resulting in the gliadin intolerance. STAT1 and IRF1 has not previously been studied in GFD treated CD children, but our results strengthen the observation by Forsberg et al indicating that intraepithelial T lymphocytes in treated, symptom-free CD patients display increased IFN-γ levels compared with controls [8] . Our results extend these findings to include the IFN-γ down stream signalling related marker STAT1.
Further, the down regulated intestinal IL-2 response in our study was not affected by the GFD treatment. This indicates that the IL-2 deficient environment is part of an immune dysregulation which leads to altered responses to dietary gliadin. Decreased intestinal IL-2 expression in CD patients has previously been reported by other groups [8] . The function of regulatory T-cells, which express high level of IL-2R, is dependent on IL-2 and TGF-β. Accordingly, low expression of IL-2 in the CD mucosa could indicate conditions in which the function of regulatory T-cells is impaired.
The function of ICOS is also dependent on the presence of IL-2 [27] . It has been shown that the function of regulatory T-cells is dependent on ICOS in insulitis [28] . In humans it has been shown that ICOS supports differentiation of Tregs when co-stimulatory signals are sub-optimal [29] .
Interestingly, in parallel with the reduction of IL-2 we found a trend for reduced expression of ICOS after GFD-treatment in the intestine. Also, the expression of the co-stimulatory molecule CD80 was decreased. Since these factors were not corrected by GFD they may represent so-called intrinsic factors related to the development of CD. The dysfunction of the IL-2-ICOS-Treg pathway in CD is supported by findings of ICOS gene polymorphism in association with CD susceptibility [30] .
We also found a down regulation of the expression of Th2 associated markers, IL-18 and CREBBP in the small intestinal biopsies of children with CD, but all these markers were normalised with GFD. CREBBP may indicate a hypoxic environment in the intestinal epithelium [31, 32] , and a Th2 down-regulation at presentation of CD likely reflects the reciprocal regulation of Th2 response by Th1 related cytokines.
Unsupervised multivariate exploratory analysis techniques e.g. PCA and cluster analysis are commonly used for analysis and visualisation of complex data sets such as expression array data [33, 34] , even though their emphasis not is the use of statistical cut-off values. In our study the PCA confirmed the results from the "traditional statistics", since the genes passing the double cut-off criteria for significant gene expression separated the study groups in the PCA-plots. Furthermore, the PCA also revealed that the intestinal and peripheral samples separated the study groups differently.
The small intestinal biopsies were taken from the participating children due to suspected CD. Three of the children were TGA-positive and thereby had high risk of CD, and two of them developed CD two years later. Two reference children were IgA-deficient and showed highest expression of Th1 genes among reference children. Accordingly, the findings of increased expression of Th1 gene markers in children with treated CD should not be enhanced but rather decreased when these children with potential CD and IgA deficiency were included in the reference group. It is also possible that normalisation of the intestinal Th1 and impaired IL-2 expression takes longer time than one year after elimination of dietary gluten. The normalisation of TGA was however seen in 6 of 7 patients as well as mucosal healing and other intestinal alterations, such as decreased Th2 gene expression profile, were normalised during the follow-up.
We are aware of the methodological limitations using whole biopsies, which unables studies of distinct cell responses/types. However, the gene expression profiles presented in our study reflects the complex disease related network of Th1-Th2-Th3 related factors in the intestine. Comparison of the local and peripheral gene expression profiles in CD revealed that the alteration of Th1, Th2 and Th3 associated markers in the intestinal biopsies was generally not reflected in peripheral blood, which puts studies of peripheral blood in tissue-specific immune diseases in question.
However, some of our results seen in peripheral blood warrant further discussion. Increased expression levels of IL-15 and IL-18 reflect activation of innate immunity in the periphery. It has been suggested that IL-15 contributes to the inflammatory response in CD by inhibition of TGF-β signalling in mucosal T cells [35] . Thus, it is not excluded that the mucosal inflammation is potentiated by systemic factors. 
